In-Vitro α-amylase, α-glucosidase Inhibitory Activities and In-Vivo Anti-Hyperglycemic Potential of Different Dosage Forms of Guduchi (Tinospora Cordifolia [Willd.] Miers) Prepared With Ayurvedic Bhavana Process

Guduchi (Tinospora cordifolia [Willd.] Miers) is a flagship rejuvenating herb of Ayurveda with reported anti-diabetic potential. In the present study, different dosage forms of Guduchi stem (growing on neem tree) were developed by adopting Ayurvedic pharmaceutical process of Bhavana (levigation). Gu...

Full description

Bibliographic Details
Main Authors: Rohit Sharma, Rajesh Bolleddu, Jayanta K. Maji, Galib Ruknuddin, Pradeep K. Prajapati
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-05-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2021.642300/full
_version_ 1819047697257070592
author Rohit Sharma
Rajesh Bolleddu
Jayanta K. Maji
Galib Ruknuddin
Pradeep K. Prajapati
author_facet Rohit Sharma
Rajesh Bolleddu
Jayanta K. Maji
Galib Ruknuddin
Pradeep K. Prajapati
author_sort Rohit Sharma
collection DOAJ
description Guduchi (Tinospora cordifolia [Willd.] Miers) is a flagship rejuvenating herb of Ayurveda with reported anti-diabetic potential. In the present study, different dosage forms of Guduchi stem (growing on neem tree) were developed by adopting Ayurvedic pharmaceutical process of Bhavana (levigation). Guduchi Churna (GC) was subjected to 07 times Bhavana separately with its own extracted juice, decoction and potable water, and dosage forms namely Svarasa Bhavita Guduchi Churna (SBGC), Kwatha Bhavita Guduchi Churna (KBGC), and Jala Bhavita Guduchi Churna (JBGC) were prepared. The present study was aimed to evaluate the role of Bhavana on the potentiation of therapeutic properties of Guduchi. Sequential solvent extracts (5, 10, 15 and 25%) of GC, SBGC, KBGC and JBGC were prepared in different solvents [phosphate buffer, hexane, dichloromethane (DCM), chloroform] and screened for the α-amylase and α-glucosidase inhibitory activity. The results revealed that phosphate buffer and DCM extracts of SBGC exhibited strong α-amylase inhibitory potential (>80% inhibition at 25% concentration) followed by KBGC, JBGC and GC with reference to the standard acarbose. In α-glucosidase inhibitory activity, maximum inhibition was observed in DCM and chloroform extracts of SBGC (>85% inhibition at 25% concentration), followed by KBGC (>80% inhibition at 25% concentration), JBGC and GC. In vivo anti-hyperglycemic studies were carried out by oral glucose tolerance test in Swiss albino mice. Test drugs (JBGC, KBGC, SBGC) treated groups showed marginal decrease of blood glucose levels in normo glycemic mice. However, the blood glucose level in test drug JBGC, KBGC and SBGC treated groups was still within normal range in overnight fasted mice. In oral glucose tolerance test, among all dosage forms SBGC (51.08%) produced pronounced anti-hyperglycemic effect followed by KBGC (42.57%) at a dose of 520 mg/kg. The GC, JBGC, KBGC and SBGC samples were also standardized using berberine (a well established anti-diabetic compound) as a marker compound by HPTLC fingerprint analysis. Findings of the present study indicate that SBGC and KBGC can be used in the treatment of diabetes mellitus and gives supporting evidence to Ayurvedic claims that the Bhavana process has pharmaceutico-therapeutic significance in Ayurvedic drug development.
first_indexed 2024-12-21T11:04:29Z
format Article
id doaj.art-aa6f1054946a463fba8318cad1590e7b
institution Directory Open Access Journal
issn 1663-9812
language English
last_indexed 2024-12-21T11:04:29Z
publishDate 2021-05-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj.art-aa6f1054946a463fba8318cad1590e7b2022-12-21T19:06:15ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122021-05-011210.3389/fphar.2021.642300642300In-Vitro α-amylase, α-glucosidase Inhibitory Activities and In-Vivo Anti-Hyperglycemic Potential of Different Dosage Forms of Guduchi (Tinospora Cordifolia [Willd.] Miers) Prepared With Ayurvedic Bhavana ProcessRohit Sharma0Rajesh Bolleddu1Jayanta K. Maji2Galib Ruknuddin3Pradeep K. Prajapati4Department of Ras Shastra and Bhaishajya Kalpana, Faculty of Ayurveda, Institute of Medical Sciences, Banaras Hindu University, Varanasi, IndiaCentral Ayurveda Research Institute, CCRAS, Ministry of AYUSH, Government of India, Kolkata, West Bengal, IndiaSociety for Research and Initiatives for Sustainable Technologies and Institutions (SRISTI), Ahmedabad, IndiaDepartment of Ras Shastra and Bhaishajya Kalpana, All India Institute of Ayurveda, University of Delhi, New Delhi, IndiaDepartment of Ras Shastra and Bhaishajya Kalpana, All India Institute of Ayurveda, University of Delhi, New Delhi, IndiaGuduchi (Tinospora cordifolia [Willd.] Miers) is a flagship rejuvenating herb of Ayurveda with reported anti-diabetic potential. In the present study, different dosage forms of Guduchi stem (growing on neem tree) were developed by adopting Ayurvedic pharmaceutical process of Bhavana (levigation). Guduchi Churna (GC) was subjected to 07 times Bhavana separately with its own extracted juice, decoction and potable water, and dosage forms namely Svarasa Bhavita Guduchi Churna (SBGC), Kwatha Bhavita Guduchi Churna (KBGC), and Jala Bhavita Guduchi Churna (JBGC) were prepared. The present study was aimed to evaluate the role of Bhavana on the potentiation of therapeutic properties of Guduchi. Sequential solvent extracts (5, 10, 15 and 25%) of GC, SBGC, KBGC and JBGC were prepared in different solvents [phosphate buffer, hexane, dichloromethane (DCM), chloroform] and screened for the α-amylase and α-glucosidase inhibitory activity. The results revealed that phosphate buffer and DCM extracts of SBGC exhibited strong α-amylase inhibitory potential (>80% inhibition at 25% concentration) followed by KBGC, JBGC and GC with reference to the standard acarbose. In α-glucosidase inhibitory activity, maximum inhibition was observed in DCM and chloroform extracts of SBGC (>85% inhibition at 25% concentration), followed by KBGC (>80% inhibition at 25% concentration), JBGC and GC. In vivo anti-hyperglycemic studies were carried out by oral glucose tolerance test in Swiss albino mice. Test drugs (JBGC, KBGC, SBGC) treated groups showed marginal decrease of blood glucose levels in normo glycemic mice. However, the blood glucose level in test drug JBGC, KBGC and SBGC treated groups was still within normal range in overnight fasted mice. In oral glucose tolerance test, among all dosage forms SBGC (51.08%) produced pronounced anti-hyperglycemic effect followed by KBGC (42.57%) at a dose of 520 mg/kg. The GC, JBGC, KBGC and SBGC samples were also standardized using berberine (a well established anti-diabetic compound) as a marker compound by HPTLC fingerprint analysis. Findings of the present study indicate that SBGC and KBGC can be used in the treatment of diabetes mellitus and gives supporting evidence to Ayurvedic claims that the Bhavana process has pharmaceutico-therapeutic significance in Ayurvedic drug development.https://www.frontiersin.org/articles/10.3389/fphar.2021.642300/fulltinospora cordifoliaguduchibhavanaα-amylaseα-glucosidaseanti-hyperglycemic
spellingShingle Rohit Sharma
Rajesh Bolleddu
Jayanta K. Maji
Galib Ruknuddin
Pradeep K. Prajapati
In-Vitro α-amylase, α-glucosidase Inhibitory Activities and In-Vivo Anti-Hyperglycemic Potential of Different Dosage Forms of Guduchi (Tinospora Cordifolia [Willd.] Miers) Prepared With Ayurvedic Bhavana Process
Frontiers in Pharmacology
tinospora cordifolia
guduchi
bhavana
α-amylase
α-glucosidase
anti-hyperglycemic
title In-Vitro α-amylase, α-glucosidase Inhibitory Activities and In-Vivo Anti-Hyperglycemic Potential of Different Dosage Forms of Guduchi (Tinospora Cordifolia [Willd.] Miers) Prepared With Ayurvedic Bhavana Process
title_full In-Vitro α-amylase, α-glucosidase Inhibitory Activities and In-Vivo Anti-Hyperglycemic Potential of Different Dosage Forms of Guduchi (Tinospora Cordifolia [Willd.] Miers) Prepared With Ayurvedic Bhavana Process
title_fullStr In-Vitro α-amylase, α-glucosidase Inhibitory Activities and In-Vivo Anti-Hyperglycemic Potential of Different Dosage Forms of Guduchi (Tinospora Cordifolia [Willd.] Miers) Prepared With Ayurvedic Bhavana Process
title_full_unstemmed In-Vitro α-amylase, α-glucosidase Inhibitory Activities and In-Vivo Anti-Hyperglycemic Potential of Different Dosage Forms of Guduchi (Tinospora Cordifolia [Willd.] Miers) Prepared With Ayurvedic Bhavana Process
title_short In-Vitro α-amylase, α-glucosidase Inhibitory Activities and In-Vivo Anti-Hyperglycemic Potential of Different Dosage Forms of Guduchi (Tinospora Cordifolia [Willd.] Miers) Prepared With Ayurvedic Bhavana Process
title_sort in vitro α amylase α glucosidase inhibitory activities and in vivo anti hyperglycemic potential of different dosage forms of guduchi tinospora cordifolia willd miers prepared with ayurvedic bhavana process
topic tinospora cordifolia
guduchi
bhavana
α-amylase
α-glucosidase
anti-hyperglycemic
url https://www.frontiersin.org/articles/10.3389/fphar.2021.642300/full
work_keys_str_mv AT rohitsharma invitroaamylaseaglucosidaseinhibitoryactivitiesandinvivoantihyperglycemicpotentialofdifferentdosageformsofguduchitinosporacordifoliawilldmierspreparedwithayurvedicbhavanaprocess
AT rajeshbolleddu invitroaamylaseaglucosidaseinhibitoryactivitiesandinvivoantihyperglycemicpotentialofdifferentdosageformsofguduchitinosporacordifoliawilldmierspreparedwithayurvedicbhavanaprocess
AT jayantakmaji invitroaamylaseaglucosidaseinhibitoryactivitiesandinvivoantihyperglycemicpotentialofdifferentdosageformsofguduchitinosporacordifoliawilldmierspreparedwithayurvedicbhavanaprocess
AT galibruknuddin invitroaamylaseaglucosidaseinhibitoryactivitiesandinvivoantihyperglycemicpotentialofdifferentdosageformsofguduchitinosporacordifoliawilldmierspreparedwithayurvedicbhavanaprocess
AT pradeepkprajapati invitroaamylaseaglucosidaseinhibitoryactivitiesandinvivoantihyperglycemicpotentialofdifferentdosageformsofguduchitinosporacordifoliawilldmierspreparedwithayurvedicbhavanaprocess